Stages:

• Early
• Expansion
• Growth
• Seed

 

Industries:

Life Sciences & Healthcare

 

Description:

The Column Group is a venture capital firm dedicated to creating the next generation of biotechnology companies. The firm will invest in approximately 10-12 disease-focused drug discovery companies (per fund), each with the potential to become a leader in their respective field(s). Typically, Column will commit $15M to $30M per company, fostering their growth from seed and early stage to later stages of development. The Column Group will primarily focus on early stage drug discovery companies, an area currently underserved by many biotech venture capital funds. The firm is currently evaluating opportunities in the areas of cancer, inflammation, infectious disease, metabolic disorders, cardiovascular disease and nervous system disorders. TCG has $2.2 billion in assets under management.

 

Funds:

Fund Name	Amount	Date
Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.